BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND H3F3A, P84243, H3_3B, MGC87783, MGC87782, H3F3, H3_3A, ENSG00000163041, 3020 AND Prognosis
70 results:

  • 1. A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.
    Auffret L; Ajlil Y; Tauziède-Espariat A; Kergrohen T; Puiseux C; Riffaud L; Blouin P; Bertozzi AI; Leblond P; Blomgren K; Froelich S; Picca A; Touat M; Sanson M; Beccaria K; Blauwblomme T; Dangouloff-Ros V; Boddaert N; Varlet P; Debily MA; Grill J; Castel D
    Acta Neuropathol; 2023 Dec; 147(1):2. PubMed ID: 38066305
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinicohistoradiological and surgical outcome in diffuse midline glioma.
    Kumar Suman A; Bhattacharjee S; Uppin MS; Fathima ST
    Childs Nerv Syst; 2024 Jan; 40(1):65-71. PubMed ID: 37644138
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mutational landscape of primary spinal cord astrocytoma.
    Cheng L; Zhang F; Zhao X; Wang L; Duan W; Guan J; Wang K; Liu Z; Wang X; Wang Z; Wu H; Chen Z; Teng L; Li Y; Xiao F; Fan T; Jian F
    J Pathol; 2023 Jul; 260(3):317-328. PubMed ID: 37114614
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Diffuse midline glioma with H3K27 alteration in adults: a clinicopathological analysis].
    Yang QY; Li MN; Chen TY; Liu C; Li X; Shi ZM; Pan MH
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):376-383. PubMed ID: 36973199
    [No Abstract]    [Full Text] [Related]  

  • 5. Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence.
    Tamura R; Iwanami A; Ohara K; Nishimoto M; Pareira ES; Miwa T; Tsuzaki N; Kuranari Y; Morimoto Y; Toda M; Okano H; Nakamura M; Yoshida K; Sasaki H
    Brain Tumor Pathol; 2023 Apr; 40(2):109-123. PubMed ID: 36892668
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series.
    Kibe Y; Motomura K; Ohka F; Aoki K; Shimizu H; Yamaguchi J; Nishikawa T; Saito R
    Sci Rep; 2023 Jan; 13(1):23. PubMed ID: 36646712
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The clinicopathological features and prognosis of multifocal high-grade gliomas in adults with
    Zhao Y; Chen Y; Wang L; Gao Y; Xu J
    Neurosciences (Riyadh); 2023 Jan; 28(1):42-47. PubMed ID: 36617452
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular Characterization of Adult tumors Diagnosed as Cerebellar Glioblastomas Identifies Subgroups Associated With prognosis.
    Picart T; Poncet D; Barritault M; Bauchet L; Zouaoui S; Guyotat J; Gabut M; Fina F; Honnorat J; Figarella-Branger D; Pallud J; Ducray F; Meyronet D; ;
    Am J Surg Pathol; 2023 Jan; 47(1):131-144. PubMed ID: 36418240
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The prognostic significance of HIST1H3B/C and h3f3a K27M mutations in diffuse midline gliomas is influenced by patient age.
    Vuong HG; Ngo TNM; Le HT; Dunn IF
    J Neurooncol; 2022 Jul; 158(3):405-412. PubMed ID: 35606633
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diffuse Midline Gliomas With Histone H3 K27M Mutation in Adults and Children: A Retrospective Series of 164 Cases.
    Zheng L; Gong J; Yu T; Zou Y; Zhang M; Nie L; Chen X; Yue Q; Liu Y; Mao Q; Zhou Q; Chen N
    Am J Surg Pathol; 2022 Jun; 46(6):863-871. PubMed ID: 35416795
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Diffuse midline gliomas with H3K27 alteration in children: a clinicopathological analysis of forty-one cases].
    Li J; Ma YY; Feng J; Zhao D; Ding F; Tian L; Chen R; Zhao R
    Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):319-325. PubMed ID: 35359043
    [No Abstract]    [Full Text] [Related]  

  • 12. [Diffuse midline glioma].
    Saito R
    No Shinkei Geka; 2022 Jan; 50(1):29-38. PubMed ID: 35169084
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pediatric spinal cord diffuse midline glioma, H3 K27-altered with intracranial and spinal leptomeningeal spread: A case report.
    Serrallach BL; Tran BH; Bauer DF; Mohila CA; Adesina AM; McGovern SL; Lindsay HB; Huisman TA
    Neuroradiol J; 2022 Oct; 35(5):634-639. PubMed ID: 34989626
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Diagnostic challenges of an incidental finding: case report of definitely-congenital glioblastoma multiforme in a very preterm infant.
    Martini S; Paoletti V; Maffei M; Zucchelli M; Locatelli C; Fischer M; Fabbri VP; Foschini MP; Tallini G; Corvaglia L
    Ital J Pediatr; 2021 Dec; 47(1):234. PubMed ID: 34906194
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Driver Genetic Mutations in Spinal Cord Gliomas Direct the Degree of Functional Impairment in tumor-Associated Spinal Cord Injury.
    Nagashima Y; Nishimura Y; Ohka F; Eguchi K; Aoki K; Ito H; Nishii T; Oyama T; Hara M; Kitano Y; Masaki H; Wakabayashi T; Natsume A
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685506
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic and Predictive Biomarkers in Gliomas.
    Śledzińska P; Bebyn MG; Furtak J; Kowalewski J; Lewandowska MA
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638714
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Evolving Molecular Landscape of High-Grade Gliomas.
    Pinarbasi E; Pratt D
    Cancer J; 2021 Sep-Oct 01; 27(5):337-343. PubMed ID: 34570447
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Epigenome-wide data collection in a case of gliofibroma.
    Behling F; Hennersdorf F; Schittenhelm J
    Folia Neuropathol; 2021; 59(2):212-218. PubMed ID: 34284549
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR.
    Li D; Bonner ER; Wierzbicki K; Panditharatna E; Huang T; Lulla R; Mueller S; Koschmann C; Nazarian J; Saratsis AM
    Sci Rep; 2021 Mar; 11(1):5098. PubMed ID: 33658570
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline.
    Velázquez Vega JE; Brat DJ; Ryken TC; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):143-164. PubMed ID: 33215342
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.